These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10508037)

  • 1. Effects of cilastatin on the pharmacokinetics of a new carbapenem, DA-1131, in rats, rabbits, and dogs.
    Kim SH; Kwon JW; Kim WB; Lee MG
    Antimicrob Agents Chemother; 1999 Oct; 43(10):2524-7. PubMed ID: 10508037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of water deprivation for 72 hours on the pharmacokinetics of a new carbapenem, DA-1131, in rats.
    Kim SH; Kwon JW; Kim WB; Lee I; Lee MG
    Life Sci; 2002 Sep; 71(19):2291-8. PubMed ID: 12215376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of brush border dipeptidase with cilastatin reduces toxic accumulation of cyclosporin A in kidney proximal tubule epithelial cells.
    Pérez M; Castilla M; Torres AM; Lázaro JA; Sarmiento E; Tejedor A
    Nephrol Dial Transplant; 2004 Oct; 19(10):2445-55. PubMed ID: 15252165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of a new carbapenem, DA-1131, after intravenous administration to rats with alloxan-induced diabetes mellitus.
    Kim SH; Kim WB; Lee MG
    Biopharm Drug Dispos; 1998 Jul; 19(5):303-8. PubMed ID: 9673782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of a new carbapenem, DA-1131, after intravenous administration to rats with uranyl nitrate-induced acute renal failure.
    Kim SH; Shim HJ; Kim WB; Lee MG
    Antimicrob Agents Chemother; 1998 May; 42(5):1217-21. PubMed ID: 9593153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of probenecid on the renal excretion mechanism of a new carbapenem, DA-1131, in rats and rabbits.
    Kim SH; Kim WB; Lee MG
    Antimicrob Agents Chemother; 1999 Jan; 43(1):96-9. PubMed ID: 9869572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and tissue distribution of a new carbapenem DA-1131, after intravenous administration to mice, rats, rabbits and dogs.
    Kim SH; Kwon JW; Lee MG
    Biopharm Drug Dispos; 1998 May; 19(4):219-29. PubMed ID: 9604121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics in healthy subjects of FCE 22101 and its acetoxymethyl ester, FCE 22891: effect of co-administration of imipenem/cilastatin on the renal metabolism of FCE 22101.
    Norrby SR; Burman LA; Sassella D; Corigli R; Cassinelli G; Franceschi G; Dornbusch K
    J Antimicrob Chemother; 1990 Mar; 25(3):371-83. PubMed ID: 2338416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cilastatin protects against cisplatin-induced nephrotoxicity without compromising its anticancer efficiency in rats.
    Humanes B; Lazaro A; Camano S; Moreno-Gordaliza E; Lazaro JA; Blanco-Codesido M; Lara JM; Ortiz A; Gomez-Gomez MM; Martín-Vasallo P; Tejedor A
    Kidney Int; 2012 Sep; 82(6):652-63. PubMed ID: 22718191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No effect of probenecid on the renal excretion mechanism of a new carbapenem, DA-1131, in dogs.
    Kim SH; Kim WB; Lee MG
    Res Commun Mol Pathol Pharmacol; 1998 Jul; 101(1):85-92. PubMed ID: 9755846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cilastatin on renal handling of vancomycin in rats.
    Kusama M; Yamamoto K; Yamada H; Kotaki H; Sato H; Iga T
    J Pharm Sci; 1998 Sep; 87(9):1173-6. PubMed ID: 9724573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic changes of a new carbapenem, DA-1131, after intravenous administration to spontaneously hypertensive rats and deoxycorticosterone acetate-salt-induced hypertensive rats.
    Kim SH; Kim WB; Lee MG
    Drug Metab Dispos; 1999 Jun; 27(6):710-6. PubMed ID: 10348801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The renal membrane dipeptidase (dehydropeptidase I) inhibitor, cilastatin, inhibits the bacterial metallo-beta-lactamase enzyme CphA.
    Keynan S; Hooper NM; Felici A; Amicosante G; Turner AJ
    Antimicrob Agents Chemother; 1995 Jul; 39(7):1629-31. PubMed ID: 7492120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An overview of the pharmacology of imipenem/cilastatin.
    Drusano GL
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():79-92. PubMed ID: 3546249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cilastatin-insulin interaction in the rat.
    Tompkins GC; Brunner LJ; Luke DR
    Drug Metab Dispos; 1989; 17(1):54-7. PubMed ID: 2566470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephroprotective effect of betamipron on a new carbapenem, DA-1131, in rabbits.
    Kim SH; Kim WB; Kwon JW; Lee MG
    Biopharm Drug Dispos; 1999 Apr; 20(3):125-9. PubMed ID: 10211864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cilastatin protects against tacrolimus-induced nephrotoxicity via anti-oxidative and anti-apoptotic properties.
    Luo K; Lim SW; Jin J; Jin L; Gil HW; Im DS; Hwang HS; Yang CW
    BMC Nephrol; 2019 Jun; 20(1):221. PubMed ID: 31200653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cilastatin attenuates cisplatin-induced proximal tubular cell damage.
    Camano S; Lazaro A; Moreno-Gordaliza E; Torres AM; de Lucas C; Humanes B; Lazaro JA; Milagros Gomez-Gomez M; Bosca L; Tejedor A
    J Pharmacol Exp Ther; 2010 Aug; 334(2):419-29. PubMed ID: 20435919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of thienamycin and related carbapenem antibiotics by the renal dipeptidase, dehydropeptidase.
    Kropp H; Sundelof JG; Hajdu R; Kahan FM
    Antimicrob Agents Chemother; 1982 Jul; 22(1):62-70. PubMed ID: 7125632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cilastatin protects against imipenem-induced nephrotoxicity
    Huo X; Meng Q; Wang C; Zhu Y; Liu Z; Ma X; Ma X; Peng J; Sun H; Liu K
    Acta Pharm Sin B; 2019 Sep; 9(5):986-996. PubMed ID: 31649848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.